Medindia
Take charge of your health! Click Here
Medindia » Indian Health News

Tamil Nadu Backs Nilavembu Kudineer to Cure Dengue

by Bidita Debnath on October 19, 2017 at 7:03 PM

A total of 10,032 cases of the fever have been reported in Tamil Nadu this year. As many as 35 people have died of dengue in the state since January 2017.


To treat this epidemic, the Tamil Nadu government decided to distribute a traditional Siddha herbal concoction, nilavembu kudineer, free of cost. The Central Council for Research in Siddha, working under the Ministry of AYUSH, has said that the concoction works not just for treating the disease but also to prevent it.

‘Nilavembu kudineer is an Antipyretic (used to prevent or reduce fever), Analgesic (pain-relieving) and can be used to treat dengue.’

A day after there were reports stating that nilavembu kudineer, a concoction used to treat dengue, could reduce fertility, Tamil Nadu Health Minister Vijayabhaskar denied these rumours and said that action will be taken against those who spread rumours on social media.

Addressing the media after visiting Mahatma Gandhi Memorial Hospital in Trichy, Vijayabhaskar said, "Nilavembu is a proven medicine, we have tested it in King Institute in Guindy, it increased the platelets and immunity, it is proven. Action will be taken against people who spread rumours on social media."

The state government is distributing the liquid using mobile units and government units. "We will continue to make elaborate arrangements to distribute nilavembu kudineer to the public. Also, the government hospitals have been instructed to ensure proper hydration of all fever patients by keeping ready nilavembu kudineer, ORS, kanji (gruel). Special medical teams have been dispatched to the vulnerable districts such as Salem, Dharmapuri and Tiruvannamalai," Tamil Nadu health minister Vijayabaskar said.

In a tweet, meanwhile, actor Kamal Haasan asked his fans to "not engage in the distribution of Nilavembu till the results of proper studies are out." He said,"let other activities continue."

Source: Medindia

View Non AMP Site | Back to top ↑